Sutro Biopharma, Inc. (STRO)
16.03
+0.69
(+4.50%)
USD |
NASDAQ |
Sep 21, 10:33
Sutro Biopharma Total Long Term Debt (Quarterly) : 243.19M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 243.19M |
| March 31, 2026 | 235.14M |
| December 31, 2025 | 227.43M |
| September 30, 2025 | 219.58M |
| June 30, 2025 | 211.62M |
| March 31, 2025 | 203.93M |
| December 31, 2024 | 196.48M |
| September 30, 2024 | 189.63M |
| June 30, 2024 | 183.50M |
| March 31, 2024 | 177.86M |
| December 31, 2023 | 176.33M |
| September 30, 2023 | 32.00M |
| June 30, 2023 | 36.72M |
| March 31, 2023 | 41.31M |
| December 31, 2022 | 45.84M |
| September 30, 2022 | 50.32M |
| June 30, 2022 | 54.35M |
| Date | Value |
|---|---|
| March 31, 2022 | 56.90M |
| December 31, 2021 | 56.34M |
| September 30, 2021 | 57.04M |
| June 30, 2021 | 24.82M |
| March 31, 2021 | 24.68M |
| December 31, 2020 | 24.54M |
| September 30, 2020 | 24.41M |
| June 30, 2020 | 24.28M |
| March 31, 2020 | 24.16M |
| December 31, 2019 | 9.876M |
| September 30, 2019 | 11.34M |
| June 30, 2019 | 12.81M |
| March 31, 2019 | 14.27M |
| December 31, 2018 | 14.72M |
| September 30, 2018 | 14.68M |
| December 31, 2017 | 16.34M |
| September 30, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Upstream Bio, Inc. | 0.226M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |
| Savara, Inc. | 30.11M |